Decision Analysis & Portfolio Management Masterclass
BOSTON | 2025
-
Course Leader: Dr. Richard Bayney,
President & Founder of Project & Portfolio Value Creation.
INTERNATIONAL MASTERCLASS
MASTERCLASS OVERVIEW
Learn how to frame decision problems and apply Decision
Analysis to solve them on the basis of maximization of eNPV.
Apply a holistic Portfolio Management framework (CREOPM
TM ) to facilitate portfolio selection under constrained resource
conditions using project prioritization and portfolio optimization.
Finally, examine the impact of linking strategic, portfolio, and
business plans interdependently.
AUDIENCE
This masterclass is particularly interesting for industry
professionals across Pharma, Biotech, Medical Devices, and Consumer Care involved in:
- Project, Program & Portfolio Management
- Research
- Clinical Development
- Resource Management
- Forecasting & Competitive Intelligence
- Marketing
- Licensing & Business Development
- Finance
- Commercialization
- Consultants are NOT permitted to attend
MEET THE
Masterclass leader
Dr. Richard Bayney is President of Project & Portfolio Value Creation (PPVC), a consulting boutique that he founded in 2008 which provides training and education in Project, Program, Portfolio, Resource, and Risk Management as well as Business, Strategic, Portfolio, and Scenario Planning services. He is an adjunct faculty member at the University of Pennsylvania.
Dr. Bayney is a 23-year veteran of the Pharmaceutical & Biotechnology industry at Merck & Co., Bayer Corp. and AG, Bristol-Myers Squibb, and Johnson & Johnson Pharmaceutical Research & Development. In his previous position at Johnson & Johnson, Richard was Vice President, Portfolio Management & Decision Analysis. Dr. Bayney obtained his M.Sc. and Ph.D. from the University of London, MBA from Columbia University, and PMP from the Project Management Institute.
TOPIC SNEAK PEEK
- The value of decision framing and the Decision Quality cycle
- The discipline of Decision Analysis and the application of Decision Trees
- Project and program risk analysis and risk management
- Integrated asset valuation using Decision Analysis and sensitivity analysis to variables
- Portfolio Management from Drug Discovery through Clinical Development to Registration
- The CREOPMTM framework for portfolio value maximization
- Creating portfolio value using Multiple Objective Decision Analysis (MODA) in prioritization
- Maximizing portfolio value using Linear Programming (LP) in optimization
- Linking strategic, portfolio, and business plans
- Examining the importance of decision-making and Portfolio Management capability maturity models
Industry Pioneers Attending From
Testimonials
Rated 5 out of 5
The careful selection of attendees made for a great exchange of ideas and best practices as well as many insightful conversations, especially at the afternoon roundtables. Looking forward to the next round at Why Summit in Munich 2025!
Christine Weitbrecht
Former Denk Pharma
Rated 5 out of 5
Conferences like these offer a unique opportunity for industry professionals to exchange knowledge, network, and stay abreast of the latest trends and developments shaping the generics market. Hopefully, you gained valuable insights and connections to further enhance your work in this field.
Ana Gavaldá
Founder & CEO, Annion
Rated 5 out of 5
It was truly my pleasure to be a part of this event, and I look forward to implementing the newfound wisdom and learnings into my daily work!
Guillermo Ducay de la Riva
Head of Legal and Senior Key Account Manager, Tiefenbacher Group
Rated 5 out of 5
Asking WHY? is a good way of staying hashtag#agile alongside career maturity. Why Summits encourages being curious, creating very open and inspiring atmosphere for professional talks. This time at 2nd PPM for Generics I was delighted to synchronize watches with passionate experts in Portfolio, Project and Business Development to a) see that the outstanding challenges and questions are the same (apart from war, of course) and b) what's more important - to get insights and ideas for future hashtag#growth!
Anna Shestakova, MBA
Portfolio Development & Launch Manager, Stada
Rated 5 out of 5
Last week there was an interesting and unique pharma conference in Munich: Global Project Management, Portfolio planning and Partnership for Generics. A shout-out to everyone that participated and attended my Lego workshop through which we explained the importance of managing our stakeholders, how we effectively communicate with them and how to make a team understand its mission and vision to motivate them and give them purpose. It was great being part of this conference and getting to meet pioneers of our field.
Konstantinos Chatzivarytis
Sr. Manager Practice Lead Agile Coach, Pfizer
Rated 5 out of 5
It was a delight to participate as a speaker at the 2nd Global Project Management, Portfolio Planning & Partnerships for Generics conference hosted by Why Summits in Munich.
The conference also provided a wonderful opportunity to connect with many brilliant minds in the pharmaceutical generic sector, allowing me to expand my network with numerous talented and knowledgeable professionals.
Ahmed Saeed Khalil
Regulatory Special Projects Lead - Global RA, Sandoz
Everything you need to know about this masterclass in one spot.
Check out our masterclass overview and agenda for this Masterclass.
